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Abstract  26 
The study aimed to establish a relationship of ethnicity to diastolic dysfunction in subjects of 27 
African-Caribbean and South Asian origins and the impact of diastolic dysfunction and 28 
ethnicity on all-cause and cardiovascular mortality. 29 
Hypertensive subjects with ejection fraction ≥55% and no history of ischemic heart 30 
disease/valve pathology (n=1546, 830 South Asians and 716 African-Caribbeans) were 31 
identified from the Ethnic - Echocardiographic Heart of England Screening Study (E-32 
ECHOES). Diastolic function and cardiac remodelling were measured by echocardiography.  33 
African-Caribbean ethnicity was associated with lower prevalence of having diastolic 34 
dysfunction (odds ratio 0.67, 95% confidence interval 0.51-0.87, p=0.003) and increased left 35 
ventricular filling pressure (odds ratio 0.48, 95% confidence interval 0.34-0.69, p<0.001) as 36 
well as lower left atrial index (p<0.001). This was the case despite the fact that African-37 
Caribbean ethnicity was independently associated with higher left ventricular mass index 38 
(p<0.001). Ninety-two deaths (6%) occurred during 68±21 months follow up. On Cox 39 
regression analysis, South Asian ethnicity (p=0.024) was predictive of all-cause death before 40 
adjustment for parameters of diastolic dysfunction, but it was no longer predictive of death 41 
after accounting for these variables. 42 
South Asian ethnicity is independently associated with worse parameters of diastolic function 43 
in hypertension, despite African-Caribbeans having more prominent hypertrophy. 44 
45 
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Introduction 46 
 47 
Hypertension is a major cause of heart failure with preserved ejection fraction (HFpEF), 48 
which is commonly associated with poor quality of life and poor outcomes.(1, 2) Diastolic 49 
dysfunction and increased myocardial stiffness are recognised pathogenic factors contributing 50 
to the development of HFpEF in hypertension.(3, 4) 51 
There are significant ethnic differences in prevalence and outcome of hypertension, with 52 
overall cardiovascular morbidity and mortality being substantially higher in South Asian and 53 
African-Caribbean ethnic groups than in the white population. Adults of African-Caribbean 54 
origin have higher blood pressure and are more prone to develop hypertension than white 55 
subjects, with more controversial data regarding people of South Asian origin.(5-7) Whilst 56 
the impact of different factors on the development of diastolic dysfunction has been 57 
extensively studied in white subjects, limited information is available on the occurrence of 58 
diastolic dysfunction in hypertensive patients of African-Caribbean and South Asian origin, 59 
and the factors associated with progression to diastolic dysfunction in these ethnic groups. 60 
The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES) was a cross-61 
sectional community-based survey of subjects of South Asian origin (i.e. from India, Pakistan 62 
or Bangladesh) and African-Caribbean origin aged ≥45 years. The two ethnic groups were 63 
recruited in parallel. All individuals living in the recruitment area and belonging to these 64 
ethnic groups were included if they were agreeable to participate in the study. The study 65 
individuals were recruited from September 2006 to August 2009 from 20 primary care 66 
centres in Birmingham, United Kingdom and the collected data included comprehensive 67 
clinical assessment and echocardiography.(8) The present ancillary E-ECHOES analysis 68 
assesses the prevalence of diastolic dysfunction and factors predicting its occurrence in a 69 
well-characterized population of adult African-Caribbean and South Asian hypertensive 70 
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subjects. The study also evaluates the impact of diastolic dysfunction and ethnicity on all-71 
cause and cardiovascular mortality. 72 
73 
 5
Methods 74 
 75 
We included participants of the E-ECHOES study who had a history of hypertension with 76 
normal left ventricular (LV) systolic function (i.e., LV ejection fraction ≥55% by 77 
echocardiography) and no history of ischemic heart disease (i.e., no angina, previous 78 
coronary revascularization or myocardial infarction or use of nitrates) (Figure 1). Other 79 
exclusion criteria were abnormalities of cardiac valves (i.e., stenosis or more than mild 80 
regurgitation of any valve or previous valve surgery), history of peripheral artery disease, 81 
cancer, chronic obstructive pulmonary disease, atrial fibrillation, current treatment with 82 
digoxin, warfarin, ADP (adenosine diphosphate receptor) antagonists or antiarrhythmic 83 
agents (except beta-blockers or calcium antagonists). The E-ECHOES database has 5353 84 
entries including 2675 patients with hypertension. A total of 1546 subjects were analysed, 85 
after all exclusion criteria were applied.  86 
The E-ECHOES study was approved by Walsall Local Research Ethics Committee 87 
(05/Q2708/45) with all participants provided written informed consent for data collection and 88 
analysis. Following patient recruitment data on outcomes (i.e. mortality) have been collected 89 
prospectively. This is provided by the Health and Social Care Information Centre 90 
(www.hscic.gov.uk). 91 
 92 
Echocardiography  93 
All study participants underwent detailed echocardiographic analysis with images reviewed 94 
by a consultant cardiologist with expertise in echocardiography. Echocardiography was done 95 
in primary care settings using a portable VIVID i machine (GE Healthcare, Chalfont St Giles, 96 
UK). LV ejection fraction, dimensions of the cardiac chambers, LV mass index and 97 
parameters of the diastolic function (mitral valve E/A ratio; E wave deceleration time; tissue 98 
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Doppler imaging of lateral and septal mitral valve annulus to quantify average septal-lateral 99 
E/e’ ratio) were also measured following current recommendations.(9)  100 
 101 
Presence of diastolic dysfunction was determined based on E/A ratio and average septal-102 
lateral E/e’ as main criteria and additional criteria of abnormal deceleration time (<130 msec 103 
or >230 msec), reduced e’ velocity (e’ septal <8 cm/sec or e’ lateral <10 cm/sec) and 104 
increased LA diameter (>4.0 cm in men and >3.8 cm in women). Diastolic dysfunction was 105 
defined as (i) E/A <1 (in patients older 60 years only in presence of ≥1 additional factor); (ii) 106 
E/A ≥1, E/e’ 8-13 and ≥1 additional factor, or (iii) E/A ≥1 and E/e’ ≥13. The coding was 107 
done by an independent colleague who was not involved in any analyses or writing of the 108 
manuscript (MD, please see acknowledgement). Increased LV filling pressure was defined 109 
based on average septal-lateral E/e’ ≥13).(10) To assess the separate components of diastolic 110 
function, average septal-lateral e' velocity (as a measure of active relaxation) and the ratio of 111 
E/e' ratio : LV diastolic volume index (as an index of passive diastolic stiffness) were 112 
calculated. LV hypertrophy was defined as LV mass index >95 g/m2 in women and 115 g/m2 113 
in men (concentric hypertrophy if relative wall thickness was ≤0.42 and eccentric 114 
hypertrophy if relative wall thickness >0.42). Concentric remodelling was defined as a 115 
normal LV mass index with relative wall thickness >0.42.(9) Echocardiographic 116 
measurements and measurements of blood pressure and heart rate were performed in 117 
triplicates and their averages were used for the analysis. 118 
 119 
Statistical analysis 120 
Data were tested for normality graphically by histogram plotting and using Kolmogorov-121 
Smirnov test. Normal data are presented as mean ± standard deviation and compared using 122 
independent sample T-test. Regression analysis was used to establish predictors of 123 
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parameters of diastolic dysfunction with the following predictor variables tested: age, gender, 124 
ethnicity, history of diabetes and smoking, systolic and diastolic blood pressure, heart rate, 125 
body mass index, waist circumference, use of angiotensin enzyme inhibitors or angiotensin 126 
receptor antagonists, aldosterone antagonists, beta-blockers, calcium channel blockers, 127 
diuretics, aspirin, statins, LV mass index (NB. the last parameter was not used in analyses of 128 
predictors of the LV mass index itself). Linear regression was used to establish predictors of 129 
continues variables and logistic regression was used to identify predictors of diastolic 130 
dysfunction and increased LV filling pressure). To further assess a possibility that observed 131 
higher LV stiffness in South Asian individuals may be related to higher prevalence of 132 
diabetes a sensitivity analysis was performed excluding people with a history of diabetes. 133 
Stepwise Cox regression analysis was used to establish predictors of all-cause and 134 
cardiovascular mortality in the study population. LA diameter index quartiles were coded as 135 
quartile 1 (i.e., less 1.51 cm/m2), quartile 2 (i.e., from 1.51 to less 1.69 cm/m2), quartile 3 136 
(i.e., from 1.69 to less 1.88 cm/m2), and quartile 4 (i.e., 1.88 cm/m2 or more) with dummy 137 
variables used to assess contrasts. Proportional hazards assumption for Cox models was 138 
graphically checked by plotting partial residuals against time for continues variables and 139 
using log minus log plots for categorical variables. P-values of <0.05 were considered as 140 
statistically significant. IBM SPSS Statistics 21 (IBM Inc, USA) software was used for 141 
statistical analyses. Figure 2 was prepared using STATA 13, marginsplot command package 142 
(StataCorp, USA). The figure presents adjusted linear regression lines with standard errors 143 
for individual age categories. The adjustment was made for the same parameters as described 144 
for the multivariable linear regression analysis above. 145 
146 
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Results 147 
 148 
A total of 1546 subjects were included (830 of South Asian origin and 716 of African-149 
Caribbean origin). Among the 830 South Asian patients 772 (93%) were born in India, 150 
Pakistan or Bangladesh, only 6 (0.7%) patients were born in the UK and 3 in other parts of 151 
Europe, with the rest 49 (6%) patients born in other parts of the world (mostly from countries 152 
of East Africa). The mean age of coming to the UK was 26±13 years and the mean duration 153 
since coming to the UK was 36±12 years. Among the 716 participants of African-Caribbean 154 
origin 621 (87%) were born on the Caribbean islands (majority – 547 (76%) in Jamaica), 70 155 
(9.8%) in the UK and 25 (3.5%) in other countries. The mean age of coming to the UK was 156 
24±11 years and the mean duration since coming to the UK was 43±13 years. 157 
Compared to participants of South Asian origin, African-Caribbeans were older (p<0.001), 158 
had a higher body mass index (p<0.001), and higher systolic blood pressure (p=0.002), but 159 
smaller waist circumference (p<0.001), lower heart rate (p<0.001) (Table 1). There were no 160 
statistical differences in gender, LV ejection fraction, diastolic blood pressure and history of 161 
smoking.  162 
South Asian patients had higher rates of diabetes (47% vs. 35%, p<0.001) and more 163 
frequently received angiotensin converting enzyme inhibitors or angiotensin receptor 164 
blockers, aldosterone antagonists and statins, but less often amlodipine, diuretics and alpha-165 
blockers. There was no significant difference in utilisation of aspirin or beta-blockers 166 
between the two ethnic groups. 167 
 168 
Diastolic dysfunction 169 
Overall 73% of South Asian subjects and 72% of African-Caribbean participants had 170 
diastolic dysfunction (p=0.74). On logistic regression analysis, independent predictors of 171 
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diastolic dysfunction were more advanced age, female gender, South Asian ethnicity, higher 172 
LV mass index, diastolic blood pressure, heart rate, waist circumference and use aldosterone 173 
antagonists (Table 2). 174 
 175 
Increased left ventricular filing pressure  176 
Increased LV filling pressure was found in 14% of South Asian patients and 11% of African-177 
Caribbean patients (p=0.09). On logistic regression analysis, independent predictors of 178 
increased LV filling pressure were advanced age, female gender, South Asian ethnicity, 179 
higher LV mass index and systolic blood pressure (p<0.001 for all). 180 
 181 
e' velocity 182 
On linear regression analysis, independent predictors of lower e’ velocity were advanced age, 183 
female gender, history of diabetes, higher LV mass index and lower waist circumference and 184 
diastolic blood pressure (p<0.001), but not the ethnicity (Table 3, Figure 2). 185 
 186 
Ratio of E/e' ratio: LV diastolic volume index 187 
On linear regression analysis, independent predictors of higher ratio of E/e' ratio: LV 188 
diastolic volume index were advanced age, female gender, higher LV mass index, systolic 189 
blood pressure, South Asian ethnicity (p<0.001 for all), history of diabetes (p=0.01) and 190 
smoking (p=0.027), higher body mass index (p=0.004) and heart rate (p=0.024). South Asian 191 
ethnicity remained independently associated with higher LV stiffness in a sensitivity analysis 192 
excluding individuals with history of diabetes (Table 3). 193 
 194 
LV mass index 195 
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On linear regression analysis, predictors of LV mass index were advanced age, male gender, 196 
African-Caribbean ethnicity, higher waist circumference and systolic blood pressure 197 
(p<0.001), history of diabetes (p=0.02), use of beta-blockers (p=0.01) or calcium channel 198 
blockers (p=0.04). 199 
 200 
LA diameter index 201 
On linear regression, independent predictors of higher LA diameter index were advanced age, 202 
female gender, South Asian origin, higher values of body mass index, LV mass index, heart 203 
rate (p<0.001 for all), diastolic blood pressure (p=0.002) and history of smoking (p=0.003). 204 
 205 
All-cause and cardiovascular death 206 
Ninety-two deaths (6%) including 26 cardiovascular deaths occurred during a follow up of 207 
68±21 months. On Cox regression analysis without adjustment for parameters of diastolic 208 
dysfunction, independent predictors of all-cause death were advanced age (p<0.001), history 209 
of smoking (p<0.001), South Asian ethnicity (p=0.024) and higher heart rate (p=0.009) 210 
(Table 4). After additional adjustment for parameters of diastolic dysfunction (i.e., LV mass 211 
index, e’ velocity, E/e' ratio : LV diastolic volume index, quartiles of LA diameter index, 212 
presence of diastolic dysfunction and increased LV filling pressure [E/e’ ≥13]) independent 213 
predictors of all-cause death were advanced age (p<0.001), male gender (p=0.049), history of 214 
smoking (p=0.012), higher heart rate (p=0.003) as well as presence of diastolic dysfunction 215 
(p=0.035) and the top quartile of LA index (p=0.002, vs. 1st quartile). After adjustment for 216 
parameters of diastolic dysfunction, ethnicity was no longer an independent predictor of all-217 
cause death.  218 
 219 
Only advanced age (p<0.004) was the independent predictor of cardiovascular death. After 220 
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additional adjustment for parameters of diastolic dysfunction above, independent predictors 221 
of cardiovascular death were increased LV filling pressure (p<0.001), history of smoking 222 
(p=0.008) and the top quartile of the LA diameter index (p=0.045, vs. 1st quartile). 223 
224 
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Discussion 225 
In this study we showed, for the first time, significant differences in characteristics of 226 
diastolic dysfunction in ethnic minority groups in the United Kingdom. South Asian ethnicity 227 
was independently associated with the presence of diastolic dysfunction and increased LV 228 
filling pressure, which paralleled a higher overall mortality associated with this ethnic group. 229 
Of interest, this was despite African-Caribbeans having more prominent LV hypertrophy. In 230 
contrast, South Asian ethnicity was associated with higher LA diameter index, a recognised 231 
marker of chronic diastolic dysfunction and higher E/e' ratio : LV diastolic volume index as 232 
an index of passive diastolic stiffness. 233 
The pathophysiology of diastolic dysfunction is complex and still poorly understood. Under 234 
physiological conditions, LV pressure rapidly decays after systole, allowing low filling 235 
pressures and adequate diastolic filling. In diastolic dysfunction LV filling is compromised as 236 
a result of impairment in active (i.e., myocardial relaxation) and/or passive stiffness 237 
(increased cardiac stiffness).(11, 12) This ventricular filling defect, in turn, might reduce 238 
cardiac output contributing to heart failure symptoms in HFpEF patients. This is supported by 239 
both interventional experiments and by large population-based studies carried out using a 240 
non-invasive approach to measure diastolic stiffness.(13-15)  241 
The present study suggests that African-Caribbeans are less likely to have diastolic 242 
dysfunction despite higher myocardial mass and thickness and more extensive concentric 243 
myocardial remodelling. The fact that African-Caribbean vs. South Asian ethnicity was not 244 
associated with higher e' velocity may suggest that the intrinsic velocity of myocardial 245 
relaxation might be preserved in these patients despite myocardial thickening. This indicates 246 
relatively benign nature of LV hypertrophy in African-Caribbean, which poses a relatively 247 
low risk of diastolic dysfunction. This observation also calls for the presence of increased 248 
passive diastolic stiffness in South Asian people that lead to diastolic dysfunction despite 249 
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lower myocardial mass and thickness. This possibility is supported by higher E/e' ratio: LV 250 
diastolic volume index (an index of passive diastolic stiffness) associated with South Asian 251 
ethnicity. Excessive myocardial fibrosis is a plausible explanation, although its assessment 252 
was beyond the scope of this population-based study. 253 
The present study does not give a direct answer on how the ethnicity-related differences in 254 
diastolic dysfunction are translated into clinical outcomes. However, it provides evidence that 255 
the ethnic differences extend beyond mild changes in diastolic dysfunction and are associated 256 
to progression towards increased LV filling pressure. Published evidence, although mostly 257 
derived from white population shows that such changes are not benign and are strongly 258 
related to increased risk of cardiovascular events.(16, 17) Indeed, ethnic minorities may 259 
represent an independent predictor of increased mortality in HFpEF.(18, 19) 260 
The factors causing increased LV mass in African-Caribbean subjects are not clear but they 261 
may have a genetic predisposition. Although children of African-Caribbean origin might 262 
even have lower blood pressure compared to white children, African-Caribbeans have higher 263 
blood pressure and more often develop hypertension later in their adult life.(20, 21) Ethnic 264 
differences in blood pressure begin to emerge in adolescence and early adulthood.(22-24) 265 
The Health Surveys for England showed a crossover in blood pressure (i.e., African-266 
Caribbeans higher than whites) somewhat later, at 30-40 years of age.(25) Even after 267 
adjustment for age, body mass index, smoking, and alcohol intake African-Caribbeans still 268 
have higher odds of having hypertension.(26) Smaller nocturnal blood pressure falls and a 269 
higher prevalence of non-dipping seen in African-Caribbeans may contribute to the higher 270 
levels of hypertension-related complications seen in African-Caribbeans.(27) No such 271 
phenomenon was seen in South Asians. 272 
In a UK-based study of highly trained nationally ranked athletes black sportsmen had greater 273 
LV wall thickness and LV mass compared to white athletes thus indicating a possibility of 274 
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genetic predisposition to LV hypertrophy.(28) Large meta-analyses of genome-wide studies 275 
have found many loci significantly associated with higher blood pressure.(29) Of the 34 loci 276 
identified in the meta-analyses, 26 loci showed ethnic variations and they could be implicated 277 
in ethnic differences in hypertension.  278 
Which factors could predispose to diastolic dysfunction in South Asian individuals despite 279 
lower LV mass? Genetic or acquired predisposition to LV fibrosis may play a role. For 280 
example, diabetes is more common in South Asians and it has a negative impact on LV 281 
diastolic function in this ethnic group.(30) Microalbuminuria is more frequent in the UK 282 
South Asians compared with white people, being associated with South Asian origin even 283 
after adjustment for hypertension, diabetes and age.(31) This may indicate higher 284 
susceptibility of South Asians to target organ damage (e.g., endothelial dysfunction). The 285 
enlarged LA could predispose to increased risk of developing atrial fibrillation that would 286 
further negatively impact diastolic function, but such analysis was beyond the scope of this 287 
study.  288 
Hypertension was shown to be one of the leading attributable risk factors for mortality in 289 
South Asians but some controversy exists in this regard.(5) For example, South Asians were 290 
less likely to be adherent to antihypertensive medications, which contributed to excess in 291 
mortality.(32) In a large registry of patients with newly diagnosed hypertension, South 292 
Asians were reported to have lower mortality and risk of cardiovascular disease outcomes 293 
compared to whites.(6) The clinical implication of ethnic differences in diastolic dysfunction 294 
in South Asians thus merits further investigation.  295 
The study shows that South Asian ethnicity is independently associated with higher all-cause 296 
death in patients with hypertension, before the adjustment for parameters of diastolic 297 
function. This parallels to the independent association of South Asian ethnicity with diastolic 298 
dysfunction in this population of hypertensive subjects (dilated left atrial can be considered a 299 
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marker of longer-term abnormalities of diastolic dysfunction in patients without valvular 300 
pathology and atrial fibrillation).(10) Ethnicity was no longer independently predictive of 301 
mortality after adjustment for parameters of diastolic dysfunction.   302 
 303 
Limitations  304 
The analysis does not cover white population, but our group previously showed in a subset of 305 
the participants of the ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) trial that 306 
African-Caribbean origin was linked to higher E/e’ ratio vs. white subjects.(33) This much 307 
bigger study with more detailed assessment of diastolic dysfunction and cardiac geometry 308 
expands those observations in relation to South Asian cohort and it sheds some light on 309 
cardiac changes contributing to diastolic dysfunction in ethnic groups. LA size was assessed 310 
based on its diameter rather than volume. The ethnic differences observed in the analysis 311 
could be, at least partly, related to body composition, which was not assessed in the E-312 
ECHOES study.(34, 35) The generalizability of the findings to ethnic groups in other regions 313 
(e.g., Asia or Africa) may be limited since both studied ethnic groups were recruited in the 314 
UK. Finally, the study does not provide mechanistic insight into pathways linking the 315 
observed differences and these need to be addressed by separate studies.  316 
 317 
Conclusions 318 
In ethnic groups recruited in the UK, South Asian ethnicity is associated with worse 319 
characteristics of diastolic function in hypertension, which parallels a higher mortality 320 
associated with this ethnic group. This occurs despite the fact that African-Caribbeans have 321 
more prominent LV hypertrophy. The findings likely reflect higher myocardial stiffness in 322 
South Asians possibly due to excessive fibrosis.  323 
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Figure legends: 454 
Figure 1. Study analysis flow chart. 455 
E-ECHOES, The Ethnic-Echocardiographic Heart of England Screening Study; COPD, 456 
chronic obstructive pulmonary disease; GTN, glycerol trinitrate; IHD, ischemic heart disease; 457 
LV, left ventricular; PAD, peripheral artery disease. 458 
 459 
Figure 2. Relationship between ethnicity and echocardiographic measured of diastolic 460 
dysfunction on multivariable linear regression models. 461 
The plots present adjusted regression lines with standard errors for specific age categories.462 
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Summary Table. 463 
What is known about topic 464 
• Hypertension is a major cause of heart failure with preserved ejection fraction, which 465 
is commonly associated with poor quality of life and poor outcomes. 466 
• Diastolic dysfunction and increased myocardial stiffness are recognised pathogenic 467 
factors contributing to the development of heart failure.  468 
• Ethnic differences play a major role in coronary artery disease and hypertension. 469 
 470 
What this study adds 471 
• The present study shows for the first time that South Asian ethnicity is independently 472 
associated with worse parameters of diastolic function in hypertension, which 473 
parallels a higher mortality associated with this ethnic group.  474 
• This occurs despite the fact that African-Caribbeans have more prominent 475 
hypertrophy and more distinct concentric remodelling.  476 
• The findings are likely reflecting higher myocardial stiffness in South Asians possibly 477 
due to excessive fibrosis.  478 
Table 1. Patient characteristics 
Parameter South Asian 
African-
Caribbean p value 
n value n value 
Demographic and clinical characteristics 
Age, years 830 62±10 716 65±11 <0.001 
Male gender 830 357 [43%] 716 302 [42%] 0.74 
Diabetes 830 392 [47%] 716 250 [35%] <0.001 
Smoking 830 71 [9%] 716 110 [15%] 0.26 
Body mass index, kg/m2 825 29±5 715 30±6 <0.001 
Waist circumference, cm 830 100.2±13 716 99.8±13 <0.001 
Systolic blood pressure, mmHg 830 147±20 716 150±19 0.002 
Diastolic blood pressure, mmHg 830 84±11 716 84±10 0.86 
Heart rate, bpm 830 81±14 716 78±13 <0.001 
Echocardiography 
Left ventricular ejection fraction, % 830 66±6 716 66±6 0.22 
End-diastolic diameter index, cm/m2 830 2.46±0.3 716 2.38±0.30 <0.001 
Left ventricular mass index, g/m2 815 115±38 713 131±43 <0.001 
Left atrial diameter index, cm/m2 820 1.74±0.3 715 1.67±0.27 <0.001 
E/e’ (medial-lateral) 809 8.19±2.41 701 7.77±2.31 0.001 
E/e' ratio : LV diastolic volume index 794 0.21±0.10 694 0.20±0.09 0.064 
Isovolumic relaxation time, msec 825 94±16 705 98±15 <0.001 
Diastolic dysfunction 830 583 [73%] 716 501 [72%] 0.74 
Increased left ventricular filling 
pressure 799 109 [14%] 695 75 [11%] 0.09 
Left ventricular geometry:        Normal 127 [16%] 67 [9%] <0.001 
Concentric remodelling 211 [26%] 126 [18%] 
Eccentric hypertrophy 122 [15%] 110 [15%] 
Concentric hypertrophy 347 [43%] 409 [57%] 
Medications 
ACEIs or ARAs 830 363 [44%] 716 243 [34%] <0.001 
Aldosterone antagonists 830 182 [22%] 716 127 [18%] 0.040 
Alpha-blockers 830 37 [4%] 716 74 [10%] <0.001 
Aspirin 830 334 [40%] 716 274 [38%] 0.43 
Beta-blockers 830 131 [16%] 716 108 [15%] 0.70 
Calcium channel blockers 830 295 [36%] 716 424 [59%] <0.001 
Diuretics 830 299 [36%] 716 350 [49%] <0.001 
Statins 830 488 [59%] 716 360 [50%] 0.001 
ACEI, angiotensin converting enzyme inhibitors; ARA, angiotensin receptor antagonists. 
 
Table 2. Logistic regression analysis of factors associated with diastolic dysfunction and 
increased left ventricular filling pressure 
 Odds ratio [95% confidence interval] p value 
Diastolic dysfunction (n=1473), Chi-Square statistic 302, p<0.001 
Age, per 1 year 1.10 [1.08-1.12] <0.001 
Female gender 1.72 [1.32-2.24] <0.001 
African-Caribbean origin 0.67 [0.51-0.87] 0.003 
Diastolic blood pressure, per 1 mmHg 1.03 [1.02-1.04] <0.001 
Heart rate, per 1 bpm 1.03 [1.02-1.04] <0.001 
Waist circumference, per 1 cm 1.03 [1.02-1.04] <0.001 
Aldosterone antagonist use 1.41 [1.01-1.97] 0.04 
Left ventricular mass index, per 1 g/m2 1.01 [1.00-1.01] <0.001 
Increased left ventricular filling pressure (n=1476), Chi-Square 128, p<0.001 
Age, per 1 year 1.06 [1.04-1.07] <0.001 
Female gender 2.48 [1.73-3.56] <0.001 
African-Caribbean origin 0.48 [0.34-0.69] <0.001 
Systolic blood pressure, per 1 mmHg 1.02 [1.01-1.03] <0.001 
Left ventricular mass index, per 1 g/m2 1.01 [1.00-1.01] <0.001 
 
Table 3. Linear regression analysis of factors associated with parameters of diastolic 
dysfunction, cardiac remodelling  
 B ± standard error Beta P value 
Left ventricular mass index (n=1528, overall r2=0.15) 
Age, per 1 year 0.49±0.09 0.13 <0.001 
Female gender -14.2±1.97 -0.17 <0.001 
African-Caribbean origin 12.9±2.05 0.16 <0.001 
Waist, per 1 cm 0.45±0.08 0.14 <0.001 
Systolic blood pressure, per mmHg 0.31±0.05 0.15 <0.001 
Beta-blocker 6.90±2.69 0.06 0.01 
History of diabetes 4.62±2.04 0.06 0.02 
Calcium channel blocker 4.23±2.01 0.05 0.04 
Left atrial diameter index (n=1523, overall r2=0.21) 
Body mass index, per kg/m2 -0.014±<0.01 -0.29 <0.001 
Left ventricular mass index, per g/m2 0.002±<0.01 0.23 <0.001 
Female gender 0.088±0.02 0.16 <0.001 
African-Caribbean origin -0.082±0.01 -0.15 <0.001 
Age, per 1 year 0.003±<0.01 0.11 <0.001 
Heart rate, per 1 bpm -0.002±<0.01 -0.10 <0.001 
Diastolic blood pressure, per mmHg -0.002±<0.01 -0.08 0.002 
History of smoking -0.046±0.02 -0.077 0.003 
e’ velocity (n=1492, overall r2=0.27) 
Age, per 1 year -0.10±<0.01 -0.46 <0.001 
Waist, per 1 cm <0.01±<0.01 -0.13 <0.001 
Diastolic blood pressure, per mmHg <0.01±<0.01 -0.16 <0.001 
Left ventricular mass index, per g/m2 -0.01±<0.01 -0.14 <0.001 
Female gender -0.50±0.10 -0.11 <0.001 
History of diabetes -0.40±0.10 -0.08 0.001 
E/e' ratio : LV diastolic volume index (n=1476, overall r2=0.15) 
Age, per year <0.01±<0.01 0.265 <0.001 
Female gender 0.04±0.01 0.203 <0.001 
Systolic blood pressure, per mmHg <0.01±<0.01 0.131 <0.001 
Left ventricular mass index, per g/m2 <0.01±<0.01 -0.107 <0.001 
History of diabetes 0.01±0.01 0.065 0.010 
African-Caribbean origin -0.02±0.01 -0.097 <0.001 
Body mass index, kg/m2 0.00±<0.01 0.075 0.004 
Heart rate, per 1 bpm <0.01±<0.01 0.056 0.024 
History of smoking 0.01±0.01 0.061 0.027 
E/e' ratio : LV diastolic volume index (only patients without diabetes included) 
(n=870, overall r2=0.15)  
Age, per year 0.002±<0.001 0.244 <0.001 
Female gender 0.047±0.006 0.256 <0.001 
Systolic blood pressure, per mmHg 0.01±<0.001 0.106 0.001 
Heart rate 0.001±<0.001 0.085 0.007 
African-Caribbean origin -0.018±0.006 -0.100 0.002 
 
Table 4. Stepwise forward Cox regression analysis of factors associated with any death 
and cardiovascular death (n=1546) 
 
Hazard ratio  
[95% confidence interval] p value 
Any death (without adjustment for parameters of diastolic function*), Chi-Square 102, 
p<0.001 
Age, per 1 year 1.11 [1.08-1.13] p<0.001 
History of smoking 2.33 [1.50-3.63] p<0.001 
African-Caribbean origin 0.60 [0.39-0.93] 0.024 
Heart rate, per 1 bpm 1.02 [1.01-1.03] 0.009 
Any death (with adjustment for parameters of diastolic function*), Chi-Square 111, 
p<0.001 
Age, per 1 year 1.09 [1.06-1.12] p<0.001 
Female gender 0.61 [0.38-1.00] 0.049 
History of smoking 1.89 [1.15-3.10] 0.012 
Heart rate, per 1 bpm 1.02 [1.01-1.04] 0.003 
Presence of diastolic dysfunction 2.25 [1.06-4.78] 0.035 
Increased LA diameter index vs. 1 quartile  0.003 
4 quartile 2.92 [1.51-5.66] 0.002 
Cardiovascular death (without adjustment for parameters of diastolic function*), Chi-
Square 8.5, p=0.004 
Age, per 1 year 1.06 [1.02-1.10] 0.004 
Cardiovascular death (with adjustment for parameters of diastolic function*), Chi-
Square 27, p<0.001 
Increased LV filling pressure 4.99 [2.09-11.9] p<0.001 
History of smoking 3.03 [1.33-6.91] 0.008 
Increased LA diameter index vs. 1 quartile  0.045 
4 quartile 4.39 [1.21-15.9] 0.024 
*Parameters of diastolic dysfunction included LV mass index, e’ velocity, E/e' ratio : LV 
diastolic volume index, quartiles of LA diameter index, presence of diastolic dysfunction and 
increased LV filling pressure (E/e’ ≥13).  LA, left atrial; LV, left ventricular. 


